SCHEMBL29438860

SCHEMBL29438860

CNS(=O)(=O)c1ccc(Nc2cccc(C(F)(F)F)c2)c(C(=O)N(C)OC)c1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.51
▸ AKR1C3 P42330 2/20 0.47
▸ AKR1C2 P52895 2/20 0.47
▸ MPO P05164 3/20 0.47
▸ IDH2 P48735 4/20 0.46
▸ RXFP1 Q9HBX9 2/20 0.45
▸ YAP1 P46937 1/20 0.43
▸ TEAD4 Q15561 1/20 0.43
▸ TEAD2 Q15562 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ TNNI3K Q59H18 1/20 0.42
▸ FBP1 P09467 1/20 0.42
▸ SLC20A2 Q08357 1/20 0.42
▸ SLC20A1 Q8WUM9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22718119 1.00 MAPT (0.51) MAPTAKR1C3AKR1C2MPOIDH2
SCHEMBL22718236 0.84 AKR1C3 (0.58) MAPTAKR1C3AKR1C2MPOIDH2
SCHEMBL29438887 0.84 AKR1C3 (0.58) MAPTAKR1C3AKR1C2MPOIDH2
SCHEMBL22719735 0.83 MPO (0.68) AKR1C3AKR1C2MPORXFP1YAP1
SCHEMBL29504944 0.83 MPO (0.68) AKR1C3AKR1C2MPORXFP1YAP1
SCHEMBL26275961 0.82 IDH2 (0.44) MAPTIDH2LMNA
SCHEMBL22719775 0.81 MAPT (0.56) MAPTAKR1C3AKR1C2MPOIDH2
SCHEMBL29505053 0.81 MAPT (0.56) MAPTAKR1C3AKR1C2MPOIDH2
SCHEMBL22719612 0.81 YAP1 (0.65) MAPTAKR1C3AKR1C2MPOIDH2
SCHEMBL29505020 0.81 YAP1 (0.65) MAPTAKR1C3AKR1C2MPOIDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119954725-A TEAD inhibitors and uses thereof 医肯纳肿瘤学公司 2025-05-09 — — CN disclosed
CN-114466839-B TEAD inhibitors and uses thereof 医肯纳肿瘤学公司 2025-01-07 — — CN disclosed
EP-3976194-A2 TEAD INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-04-06 — — EP disclosed
Send feedback